Cargando…

High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis

INTRODUCTION: Systemic sclerosis (SSc) is an autoimmune disease characterized by chronic inflammation, vascular injury and excessive fibrosis. CD163 is a scavenger receptor which affects inflammatory response and may contribute to connective tissue remodelling. It has recently been demonstrated that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kowal-Bielecka, Otylia, Bielecki, Marek, Guiducci, Serena, Trzcinska-Butkiewicz, Beata, Michalska-Jakubus, Małgorzata, Matucci-Cerinic, Marco, Brzosko, Marek, Krasowska, Dorota, Chyczewski, Lech, Kowal, Krzysztof
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060194/ https://www.ncbi.nlm.nih.gov/pubmed/23800379 http://dx.doi.org/10.1186/ar4246

Ejemplares similares

Regular Training Increases sTWEAK and Its Decoy Receptor sCD163–Does Training Trigger the sTWEAK/sCD163-Axis to Induce an Anti-Inflammatory Effect?
por: Schönbauer, Robert, et al.
Publicado: (2020)

Reduced sTWEAK and Increased sCD163 Levels in HIV-Infected Patients: Modulation by Antiretroviral Treatment, HIV Replication and HCV Co-Infection
por: Beltrán, Luis M., et al.
Publicado: (2014)

Pathogenic characteristics of pulmonary infection in hospitalized patients with chronic heart failure and diagnostic value of sTREM-1, sCD163, and sTWEAK
por: Zheng, Fang
Publicado: (2022)

The Diagnostic Value of sTWEAK in Acute Ischemic Stroke
por: Comertpay, Ertan, et al.
Publicado: (2020)

Anti-endothelial cell antibodies do not correlate with disease activity in systemic sclerosis
por: Michalska-Jakubus, Małgorzata, et al.
Publicado: (2018)

Systemic corticosteroid therapy augments ex vivo release of sCD163 by peripheral blood monocytes of asthmatic patients
por: Bernatowicz, Paweł L., et al.
Publicado: (2020)

Serum Levels of Selected IL-1 Family Cytokines in Patients with Morphea
por: Szczepanik-Kułak, Paulina, et al.
Publicado: (2022)

sTWEAK is a leukoaraiosis biomarker associated with neurovascular angiopathy
por: da Silva‐Candal, Andrés, et al.
Publicado: (2022)

Evaluation of serum concentrations of the selected cytokines in patients with localized scleroderma
por: Budzyńska-Włodarczyk, Jolanta, et al.
Publicado: (2016)

Clinical associations of serum leptin and leptin/adiponectin ratio in systemic sclerosis
por: Michalska-Jakubus, Małgorzata, et al.
Publicado: (2018)

A novel miRNA-4484 is up-regulated on microarray and associated with increased MMP-21 expression in serum of systemic sclerosis patients
por: Rusek, Marta, et al.
Publicado: (2019)

Expression of LIGHT/TNFSF14 and Its Receptors, HVEM and LTβR, Correlates with the Severity of Fibrosis in Lacrimal Sacs from Patients with Lacrimal Duct Obstruction
por: Bielecki, Pawel, et al.
Publicado: (2020)

The presence of leukoaraiosis enhances the association between sTWEAK and hemorrhagic transformation
por: da Silva‐Candal, Andrés, et al.
Publicado: (2020)

Visfatin and chemerin levels correspond with inflammation and might reflect the bridge between metabolism, inflammation and fibrosis in patients with systemic sclerosis
por: Sawicka, Karolina, et al.
Publicado: (2019)

Serum sTWEAK and FGF-23 Levels in Hemodialysis and Renal Transplant Patients
por: Eskandari Naji, H., et al.
Publicado: (2017)

sTWEAK is a marker of early haematoma growth and leukoaraiosis in intracerebral haemorrhage
por: da Silva-Candal, Andrés, et al.
Publicado: (2021)

Anti-endothelial cell antibodies are associated with apoptotic endothelial microparticles, endothelial sloughing and decrease in angiogenic progenitors in systemic sclerosis
por: Michalska-Jakubus, Małgorzata M., et al.
Publicado: (2019)

The effect of resveratrol supplementation on the expression levels of factors associated with cellular senescence and sCD163/sTWEAK ratio in patients with type 2 diabetes mellitus: study protocol for a double-blind controlled randomised clinical trial
por: Abdollahi, Shima, et al.
Publicado: (2019)

sTWEAK as Predictor of Stroke Recurrence in Ischemic Stroke Patients Treated With Reperfusion Therapies
por: Hervella, Pablo, et al.
Publicado: (2021)

Circulating sTweak is associated with visceral adiposity and severity in patients with obstructive sleep apnea syndrome
por: Cilekar, Sule, et al.
Publicado: (2021)

Comparison of hyaluronic acid in patients with rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus
por: Cylwik, Bogdan, et al.
Publicado: (2021)

Inter- Not Intraindividual Differences in sTWEAK Levels Predict Functional Deterioration and Mortality in Patients with Dilated Cardiomyopathy
por: Jarr, Kai-Uwe, et al.
Publicado: (2014)

HIV-1/HAART-Related Lipodystrophy Syndrome (HALS) Is Associated with Decreased Circulating sTWEAK Levels
por: López-Dupla, Miguel, et al.
Publicado: (2015)

Reduced circulating sTWEAK levels are associated with metabolic syndrome in elderly individuals at high cardiovascular risk
por: Díaz-López, Andrés, et al.
Publicado: (2014)

Right atrial myxoma: a potential accelerator of pulmonary hypertension in the course of systemic sclerosis. The role of interleukin-6
por: Peregud-Pogorzelska, Małgorzata, et al.
Publicado: (2019)

NOTCH3 T6746C and TP53 P72R Polymorphisms Are Associated with the Susceptibility to Diffuse Cutaneous Systemic Sclerosis
por: Zmorzyński, Szymon, et al.
Publicado: (2020)

Diagnostic Power of Galectin-3 in Rheumatic Diseases
por: Gruszewska, Ewa, et al.
Publicado: (2020)

Reduced soluble TNF-like weak inducer of apoptosis (sTWEAK) and increased frap in postmenopausal women with metabolic syndrome
por: Comim, Fabio Vasconcellos, et al.
Publicado: (2015)

Laser Therapy for the Treatment of Morphea: A Systematic Review of Literature
por: Szczepanik-Kułak, Paulina, et al.
Publicado: (2021)

Regulation of eicosanoid production in peripheral blood mononuclear cells from patients with systemic sclerosis
por: Kowal-Bielecka, Otylia, et al.
Publicado: (2007)

The TWEAK/Fn14/CD163 axis—implications for metabolic disease
por: Ratajczak, Wiktoria, et al.
Publicado: (2021)

Relationship Between sCD163 and mCD163 and Their Implication in the Detection and Typing of Leprosy
por: Farag, Azza Gaber Antar, et al.
Publicado: (2020)

CD163 interacts with TWEAK to regulate tissue regeneration after ischaemic injury
por: Akahori, Hirokuni, et al.
Publicado: (2015)

Localized Blistering Eruption of the Face and Neck – A Case Study and Differential Considerations
por: Michalska-Jakubus, Małgorzata, et al.
Publicado: (2022)

Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2019)

Soluble CD163 and TWEAK in early pregnancy gestational diabetes and later glucose intolerance
por: Dereke, Jonatan, et al.
Publicado: (2019)

Clinical significance of sCD163 and its possible role in asthma
por: Zhi, Yue, et al.
Publicado: (2017)

Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection
por: Mascia, Claudia, et al.
Publicado: (2018)

Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study
por: Feng, Lin, et al.
Publicado: (2012)

Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis
por: Dobrota, Rucsandra, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rid9n419h82ua5cff3qrf4ca6k